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Transcatheter Closure of Ruptured Sinus Valsalva Aneurysms Using Patent
Ductus Arteriosus Occluders
Fang Zhenfei, Huang Yiyuan, Tang Liang, Hu Xinqun, Shen Xiangqian, Tang Jianjun,
Zhou Shenghua
Department of Cardiology, The Second Xiangya Hospital of Central South University
Objectives: Percutaneous closure of RSVA was ﬁrst attempted by Cullen et al in 1994
using a Rashkind umbrella, and since then successful transcatheter closure (TCC) is
being increasingly reported with encouraging follow-up results. To date, both large-
scale and long-term follow-up results for this technique are scarce. Thus, this study
aims to evaluate the safety and efﬁcacy of transcatheter closure of RSVA using Patent
Ductus Arteriosus Occluders and to characterize patients’ long-term clinical outcomes.
Methods: From 2004 to 2012, 17 patients (8 males, 9 females) were treated with PDA
occluders (lifetech Ltd, Shenzhen, China) by antegrade venous approach and were
followed for 18-102 months.
Results: Of the total 17 patients, Transthoracic Echocardiography (TTE) revealed the
rupture of right coronary sinus into right ventricle in 9 and into right atrium in 4, while
non-coronary sinus ruptured into right ventricle in 3 and into right atrium in 1. Most
(10/17) were in New York Heart Association (NYHA) functional class III or IV. The
Qp/Qs was 1.2 to 3.0 (mean 1.630.42). The pulmonary arterial pressures of
10 patients were normal (<25mmHg), 7 were found elevated mildly to moderately,
the mean pulmonary artery pressure (MPAP) was 25.827.52 mmHg. Aortography
showed that the size of the defect was 7.712.84 mm (4-15 mm). TCC was attempted
using PDA occluders 2-5 mm larger than the aortic end of the defects. The device
sizes ranged from 8/6-18/16 mm (median 10/8 mm): 10/8 mm in 7 patients, 12/10 mm
in 4 patients, 8/6 mm in 2 patients, 14/12 mm in 2 patients, 18/16 mm in 1 patient. The
mean procedure time was 7832 min, and the ﬂuoroscopy time was 19.110.4 min.
The procedure was successful in 16 (94.1%), and all of them had a complete occlusion
at discharge, including a high-risk patient with poor general condition and severe co-
morbidities. The largest size of RSVA been successfully closed was 12mm at the
aortic side. It is feasible and effective to perform TCC using PDA occluders in patients
of isolated RSVA with aortic end diameter<13mm. The only failure case is due to
large size of RSVA, despite deployment of the largest PDA occluder (18/16 mm),
there was an occurrence of a moderate residual shunt. On a median follow-up of 42
months, 14 patients were in NYHA class I and 2 were in class II, and there was no
residual shunt, device embolization, infective endocarditis, and aortic regurgitation.
Conclusions: This study has proved that transcatheter closure of RSVA is feasible
using a PDA occluder with preliminary immediate and long-term follow-up results. It
can be a safe and effective alternative to surgical repair for isolated RSVA. Moreover,
it is lifesaving for patients who are a high risk due to poor general condition and
severe comorbidities. Longer follow-up is required to assess the long-term outcome of
this technique.
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The ultrasonic diagnosis value for the diagnosis of congenital coronary artery
ﬁstula, compared with ﬁndings of surgery and/or coronary angiography
Sun Zhenxing, Li-Ling, Xie Ming-Xing
Union Hospital of Tongji Medical College, Huazhong University of Science and
Technology
Objectives: To evaluate the application of transthoracic echocardiography for the
diagnosis of congenital coronary artery ﬁstula.
Methods: The echocardiographic appearances of 63 patients with coronary artery
ﬁstulas who had undergone coronary angiography and/or operation in our hospital,
were analyzed retrospectively, and the results were compared with ﬁndings of surgery
and/or coronary angiography.
Results: (1) Right CAFs were detected in thity-three patients (52.4%):eleven of them
had drainages to the right atrium,ten to the right ventricle, two to the left ventricle,
nine to the main pulmonary artery, and one to the coronary sinus. Left CAFs were
detected in twenty-nine patients (46.0%): six of them had drainages to the right
atrium,twelve to the right ventricle, one to the left atrium, two to the left ventricle,
seven to the main pulmonary artery, and one to the coronary sinus. In one case (1.6%),
there is origin in both coronary arteries. Most often the entry point was a single oriﬁce
(96.8%),but,rarely,it was multiple (3.2% ). Fifty-seven patients were diagnosed sim-
plex coronary ﬁstulas (90.5%). Six patients had other congenital cardiac malforma-
tions (9.5%). (2) Twelve patients had also undergo conventional coronary
angiography (CAG) before surgery to conﬁrm the diagnosis. (3) The ultrasonographic
diagnosis of sixty was in line with surgical ﬁndings and/or coronary angiography. The
accurate rate for the diagnosis of coronary artery ﬁstula was 95.2%. Preoperative
transthoracic echocardiography had three patients who were neglected CAF. The
misdiagnosis rate was 4.8%.
Conclusions: Transthoracic echocardiography could be a primary method for diag-
nosis of congenital artery ﬁstula.
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The effects of anticoagulant therapy on coagulant state and platelet function
following transcatheter closure of atrial septal defect
Chen Guocai, Huang Lan
Cardiovascular Department of Xinqiao Hospital, Third Military Medical UniversityC192 JACC Vol 64/16/Suppl C j October 16–1Objectives: Several studies have demonstrated coagulant system was activated after
transcatheter closure of ASD, but changes of platelet function still remain contro-
versial. Currently, it is not clear which anticoagulant regiment is more effective to
prevent thrombosis and embolic events after device implantion. This study was to
compare the effects of three anticoagulant regiments on coagulant state and platelet
function following transcatheter closure of atrial septal defect (ASD).
Methods: A total 138 patients who underwent transcatheter closure of ASD were
randomized into three groups to receive different anticoagulant therapy: unfractio-
nated heparin (UFH) for 24 hours, low molecular weight heparin (LMWH) for
24 hours, and LMWH for 72 hours (pLMWH). Aspirin was given to all patients for
6 months after intervention. The laboratory measurements included beta-thrombo-
globulin (b-TG), platelet factor 4 (PF4) and prothrombin fragment 1+2 (F1+2) which
were done before intervention as baseline, immediately after, and day 1, 2, 3, 7, 30 and
90 after intervention.
Results: In 3 groups, b-TG, PF4 and F1+2 elevated immediately after implantation
procedure. b-TG and PF4 declined slightly on day 1 and 2, and rose to a highest level
on day 3, then fell down to baseline on day 7. The F1+2 gradually returned to baseline
on day 90. However, the F1+2 in pLMWH group was markedly lower than that in
UFH and LMWH groups on day 3. No thrombo-embolic events were noted during
follow-up.
Conclusions: Transcatheter closure of ASD was associated with signiﬁcant activation
of both platelets and coagulation. These ﬁndings support an antithrombotic regiment
after procedure including anticoagulant and antiplatelet agents. The F1+2 level fell
down earlier in pLMWH group. However, there were no differences of clinical out-
comes among three groups on day 90 after intervention. Therefore, a larger size and
longer follow-up study is needed to further clarify this issue.
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Pulmonary arterial and bronchial obstruction due to external compression in a
patient with chronic mycrobacterium avium infection. Successful therapy with
bronchial and pulmonary artery stent implantation
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Objectives: We report on a 2 years old patient with immunodeﬁciency and massive
general lymphadenopathy due to chronic mycoplasma avium intercellulare (MAI)
infection. Mediastinal lymphadenopathy led to complete obstruction of the left main
bronchus and the left pulmonary artery (LPA). Interventional techniques were suc-
cessfully applied to address bronchial and vascular stenosis before the patient was
referred for bone marrow transplantation (BMT).
Methods: After the anatomy was delineated by bronchiography, a pre-mounted Pal-
maz Genesis biliary stent (PB1570 PSS, diameter 7 mm) was introduced into the
proximal left main bronchus over the wire and implanted with 10 atm. Further
obstruction of the left bronchus was conﬁrmed by ﬂexible bronchoscopy through the
stent lumen, therefore two more stents (PB1560 PSS) were implanted telescopically.
Results: Bronchiography and bronchoscopy conﬁrmed complete restoration of the
lumen of the left main bronchus. After the airway was restored, the proximal LPA was
stented with a PG1910 XD crimped on a 9 mm OPTA balloon catheter. Complete
patency of the proximal LPA was conﬁrmed by angiography. The patient was extu-
bated in the catheterization laboratory and monitored in the ICU for 24 h to exclude
reperfusion edema of the left lung. Follow-up x-ray and clinical examination
conﬁrmed adequate ventilation of the left lung after stenting. The patient was dis-
charged home 36 hours after the procedure. Antithrombotic therapy was initiated with
Aspirin and anti-inﬂammatory inhalation therapy with budesonide. The patient was
then referred for BMT.
Conclusions: Bronchial and pulmonary arterial compression secondary to mediastinal
lymphadenopathy can effectively be treated in the catheterization laboratory by
endobronchial and endovascular stent implantation.
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Factors inﬂuencing the spontaneous closure of ventricular septal defect in infants
Xu Yang, Sirui Yang
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Objectives: Predictors for spontaneous closure of ventricular septal defects (VSD) in
infants are still unknown. The current study is designed to prospectively evaluate the
potential value of maternal and infantile variables as predictors for the spontaneous
VSD closure in infants.
Methods: Consecutive infants, who were less than six-month-old when diagnosed
with VSD, were followed-up for at least 5 years. Demographic, clinical and maternal
factors were evaluated for the possible associations of incidence of spontaneous VSD
closure.
Results: Of the 456 eligible infants, 93 (20.39%) had spontaneous VSD closure,
78.50% of which occurred when the patients were under 3 years of age. Results of
logistic analyses suggested that diameter of the defect (DVSD), ratio between
diameter of the defect and aortic root diameter (DVSD/DAR), left atrium sizes, left
ventricle sizes, main pulmonary forward blood ﬂow, infection scores, shunt ratio
(Qp/Qs), VSD locations (perimembranous, muscular, subarterial, or mixed-type), and
comorbidities including patent ductus arteriosus (PDA), complex congenital heart9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
disease (CHD), and membranous septal aneurysm were independent predictors of
spontaneous closure. Results of bivariate logistic regression analyses indicated the
location of VSD also had signiﬁcant impact on spontaneous closure (P<0.05). The
most appropriate cutoff value of the continuous variables for the prediction of
spontaneous closure is evaluated. (DVSD<2.85mm, DVSD/DAR <0.23, left atrium
sizes < 19.5mm, left ventricle sizes < 32.5mm, main pulmonary forward blood ﬂow
< 1.01cm/s, infection scores < 2.43, and Qp/Qs < 1.53). But the maternal factors,
(heavy drinking, et al) during the ﬁrst 3 months of pregnancy and VSD infants with
other diseases ( Down syndrome, et al) did not affect the spontaneous closure of
infants with VSD.
Conclusions: Variables such as DVSD, DVSD/DAR, left atrium sizes, left ventricle
sizes, main pulmonary forward blood ﬂow, infection scores, Qp/Qs, VSD location,
comorbidities including PDA, complex CHD, or membranous septal aneurysm may
be used as potential independent predictors of spontaneous VSD closure in infants.
But the maternal factors and with other diseases do not affect the spontaneous closure
of infants with VSD. The most appropriate cutoff value of the continuous variables for
the prediction of spontaneous closure is useful to the clinical work. Large-scale studies
are warranted to conﬁrm these ﬁndings.
GW25-e5117
Simultaneous Treatment of Native Aortic Coarctation Combined With Patent
Ductus Arteriosus Using a Covered Stent
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Objectives: Stents have assumed an important role in therapeutic catheterization
procedures for patients with congenital heart disease .In this article, we report on the
use of a covered Cheatham-Platinum (CP) stent to treat coexistent coarctation of the
aorta and patent ductus arteriosus.
Methods: A 22-year-old boy with aortic coarctation and patent ductus arteriosus
underwent simultaneous treatment of native coarctation and closure of ductus arte-
riosus using a covered Cheatham-Platinum stent.Cardiac catheterization was per-
formed under local anesthesia and the right femoral artery and vein were cannulated.
Heparin 100 u/kg was given. A descending aortogram showed a tight juxtaductal
coarctation of the aorta with poststenotic dilatation of the descending aorta and a
moderate-size patent ductus arteriosus measuring 3.1 mm at the narrowest point. The
minimum diameter of the aortic coarctation was 7 mm, the isthmus 20 mm, and the
aorta at the level of the diaphragm 24 mm.
Results: Repeat aortogram showed a good result with complete occlusion of the
ductus arteriosus with apposition of the stent to the aortic wall. There was no evidence
of dissection or aneurysm formation. The diameter of the coarctation segment after
stent implantation measured 16 mm and the diameters above and below the residual
waist were 18 and 20 mm, respectively. There was no gradient across the stented
segment. No complications occurred during the procedure.
Conclusions: This technique may be used as an alternative to other forms of inter-
ventional therapy or surgery for this combination of lesions in adolescents.
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GATA5 loss-of-function mutation underlies double outlet right ventricle.
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Objectives: Congenital heart disease (CHD) is the commonest form of birth defect in
humans and is a leading non-infectious cause of infant death worldwide. Genetic risk
factors have been implicated in the pathogenesis of CHD. However, CHD is geneti-
cally heterogeneous and the genetic basis underpinning CHD in an overwhelming
majority of patients remains unclear.
Methods: In the present study, the coding exons and exon-intron boundaries of the
GATA4, GATA5 and GATA6 genes, which encode zinc-ﬁnger transcription factors
essential for cardiogenesis, were sequenced in 130 unrelated CHD patients. A total of
200 unrelated non-CHD control individuals were genotyped for GATA5. The func-
tional characteristics of the identiﬁed GATA5 mutation were delineated by using a
luciferase reporter assay system.
Results: A novel heterozygous GATA5 mutation, P .G206R, was identiﬁed in a
1-year-old boy with double outlet right ventricle (DORV) as well as subaortic ven-
tricular septal defect. The mutation was absent in 400 control chromosomes and the
altered amino acid was completely conserved evolutionarily. Functional assaysJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Crevealed that the GATA5 mutant was associated with signiﬁcantly decreased tran-
scriptional activity compared with its wild-type counterpart.
Conclusions: This study ﬁrstly links GATA5 loss-of-function mutation to enhanced
susceptibility to DORV, providing novel insight into the molecular mechanism of
DORV.
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Changes in the pulmonary artery pressure before and after transcatheter
occlusion of congenital heart disease with left to right shunt: comparative
evaluation using invasive and non-invasive approach
Jiang Qingan, Feng Tang, Qing-An Jiang
Guizhou Provincial People’s Hospital
Objectives: To evaluate immediatel efﬁcacy of transcatheter occlution of congenital
heart disease with left to right shunt through assessing pulmonary artery pressure , and
to explore the feasibility of noninvasive echocardiographic assessment of pulmonary
arterial pressure.
Methods: A total of 107 cases of successful implementation of interventional treat-
ment of atrial septal defect, ventricular septal defect and patent ductus arteriosus were
carried out pulmonary artery pressure measurement using ultrasonic pulmonary
arterial ﬂow spectrum method and right heart catheterization before and immediately
after transcatheter occlution, respectively.
Results: The preoperative pulmonary artery pressure measured by ultrasound and was
signiﬁcantly positively related to by cardiac catheterization [ pulmonary artery systolic
pressure (PASP), r ¼ 0.810, P<0.05; pulmonary artery mean pressure (PAMP),
r ¼ 0.819, P<0.05)]. In the normal / mild pulmonary hypertension group , PASP
mildly elevated immediately after the intervention (P<0.05). In the moderate pul-
monary hypertension group, PASP and PAMP immediately after the intervention were
both signiﬁcantly decreased (both P<0.05). In the severe pulmonary hypertension
group, PASP and PAMP immediately after the intervention were both signiﬁcantly
decreased (P<0.05).
Conclusions: The ultrasound estimation of pulmonary artery pressure is highly
correlated with the measured value of cardiac catheterization , and therefore ultrasonic
pulmonary arterial ﬂow spectrum method can accurately estimate pulmonary artery
pressure ;Transcatheter treatment of transcatheter closure of left to right shunt
congenital heart disease could more effectively lowe pulmonary arterial pressure in
patients with moderate to severe pulmonary hypertension.
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Clinical applications of echocardiography in transcatheter device closure of atrial
septal defect
Cheng Yingzhang, Wang Gan, Li Yunde, Liu Yanna, Wu Qinghua, Cheng Xiaoshu
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Objectives: To report experiences of transcatheter device closure of atrial septal
defect with the help of echocardiography and X-ray.
Methods: Chose 678 inpatients including 286 male and 382 female whose age were
3w76 year old (average age was 15.6810.20 year old) who were diagnosed with
atrial septal defect according to history and echocardiography in department of
cardiology from January 2002 to October 2013. All the patients were diagnosed
with atrial septal defect by transthoracic echocardiography. 367 inpatients who were
older than 14 were required to have a transesophageal echocardiography check.
Detect defect size, aortic edge and aortic contralateral edge at the level of short axis
view of the aortic. Detect defect size, mitral edge and top edge of atrial at the level
of apical four- chamber view. Detect defect size, edge of the superior vena cava and
edge of the inferior vena cava at the level of 2- atrium plane below the xiphoid
process. Make a atrial septal defect closure with the help of echocardiography and
X-ray according to the expert consensus of common congenital heart disease
interventional therapy.
Results: The maximum defect size of 678 inpatients detected by transthoracic
echocardiography was 25.3511.16mm, the superior and inferior vena cava edge of
98 inpatients was fuzzy. The maximum defect size of 367 inpatients with the help of
transesophageal echocardiography was 28.2610.05mm, their superior and inferior
vena cava edge were clear, but the maximum defect size was 26.0610.13mm with
the help of transthoracic echocardiography (P>0.05). 651 inpatients successfully
accepted transcatheter occlusion and the success rate was 96.02%. The size of
occluder was 3010mm. 360 of 367 inpatients who accepted transesophageal
echocardiography got a successful transcatheter occlusion and the success rate was
98.09%. The size of occluder was 3211mm. We analyzed the 27 unsuccessful cases
and found that there were 12 unsuccessful cases whose aortic contralateral edge
and inferior vena cava edge were unsuitable, the failure rate was 100%, 6 of
8 cases whose inferior vena cava edge was unsuitable, the failure rate was 75%, 9 of
15 cases whose aortic contralateral edge was unsuitable, the failure rate was 60%, the
cases whose aortic edge or the superior vena cava edge was unsuitable, the failure
rate was 0.
Conclusions: The atrial septal defect size detected by transthoracic echocardiography
or transesophageal echocardiography had no statistically signiﬁcant difference. The
success rate of occluder was higher with the help of transesophageal echocardiogra-
phy. Patients have atrial septal defect with an unsuitable aortic contralateral edge and
inferior vena cava edge were inappropriate to accept interventional therapy,aortic
contralateral edge or inferior vena cava edge was unsuitable also affect the success rate
of interventional closure.ardiovascular Disease Clinical Research C193
